Stock listing
Aquis:BSLNZ Basilea Pharmaceutica AG Share Price
UK listing (Aquis) of Basilea Pharmaceutica AG · home listing SIX Swiss:BSLN
Follow Basilea Pharmaceutica AG into a list and get an email when it puts out news.
Home listing price · SIX:BSLN
72.20 CHF +3.30 (+4.8%)
Close on Oct 27, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:BSLN
- Day range
- 70.40 – 75.80 CHFOct 27, 2026
- Volume
- 151,426 sharesOct 27, 2026
- Market cap
- 894.7M CHFAt the close on Oct 27, 2026 · price × 12.39M shares outstanding
- 52-week range
- 44.70 – 75.80 CHFLowest and highest trades, Oct 28, 2025 – Oct 27, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:BSLN · Home | 72.20 CHF | +3.30 (+4.8%) | 151,426 | 72.90 | 75.80 | 70.40 | 68.90 | Close on Oct 27, 2026 |
| LSE:0QNA | 72.50 CHF | +3.65 (+5.3%) | 990 | 73.60 | 73.60 | 71.00 | 68.85 | Close on Oct 27, 2026 |
| OTC:BPMUF | $76.25 USD | 0.00 (0.0%) | — | $76.25 | $76.25 | $76.25 | $76.25 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 27, 2026 – Oct 27, 2026 · SIX:BSLN · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 72.20 | +3.30 | +4.8% | 72.90 | 75.80 | 70.40 | 151,426 | |
| 68.90 | +0.40 | +0.6% | 68.70 | 69.90 | 68.70 | 15,982 | |
| 68.50 | -0.80 | -1.2% | 69.00 | 69.60 | 67.90 | 19,776 | |
| 69.30 | +0.90 | +1.3% | 68.60 | 69.40 | 67.60 | 31,031 | |
| 68.40 | +0.90 | +1.3% | 67.90 | 68.50 | 66.40 | 22,520 | |
| 67.50 | -0.10 | -0.1% | 67.70 | 68.10 | 66.30 | 22,021 | |
| 67.60 | +2.00 | +3.0% | 65.60 | 67.60 | 65.50 | 28,973 | |
| 65.60 | -3.00 | -4.4% | 68.40 | 68.70 | 65.60 | 25,814 | |
| 68.60 | +2.10 | +3.2% | 66.80 | 68.70 | 65.80 | 43,629 | |
| 66.50 | +1.80 | +2.8% | 64.60 | 66.80 | 64.40 | 26,544 | |
| 64.70 | -1.00 | -1.5% | 65.80 | 66.70 | 64.50 | 15,702 | |
| 65.70 | +0.20 | +0.3% | 65.70 | 66.00 | 64.60 | 17,344 | |
| 65.50 | -0.20 | -0.3% | 65.60 | 66.00 | 64.40 | 23,308 | |
| 65.70 | -0.50 | -0.8% | 65.80 | 66.60 | 64.90 | 24,605 | |
| 66.20 | +0.40 | +0.6% | 65.60 | 66.20 | 64.10 | 19,848 | |
| 65.80 | -0.20 | -0.3% | 66.30 | 67.10 | 65.00 | 16,503 | |
| 66.00 | -0.80 | -1.2% | 67.00 | 67.00 | 65.90 | 18,826 | |
| 66.80 | -1.00 | -1.5% | 67.60 | 67.70 | 66.30 | 17,311 | |
| 67.80 | -2.10 | -3.0% | 69.50 | 69.50 | 67.40 | 24,214 | |
| 69.90 | +2.90 | +4.3% | 67.00 | 70.10 | 66.80 | 45,860 | |
| 67.00 | -1.30 | -1.9% | 68.00 | 68.40 | 66.40 | 20,986 | |
| 68.30 | -0.40 | -0.6% | 68.80 | 69.20 | 68.00 | 15,529 | |
| 68.70 | -0.40 | -0.6% | 69.20 | 69.40 | 68.30 | 17,433 | |
| 69.10 | -0.30 | -0.4% | 69.00 | 69.30 | 68.60 | 22,513 | |
| 69.40 | +0.80 | +1.2% | 68.70 | 69.40 | 68.30 | 27,440 | |
| 68.60 | -0.40 | -0.6% | 69.20 | 69.40 | 67.40 | 46,487 | |
| 69.00 | 0.00 | 0.0% | 69.20 | 70.50 | 68.80 | 35,900 | |
| 69.00 | 0.00 | 0.0% | 69.00 | 69.90 | 69.00 | 124,822 | |
| 69.00 | +2.50 | +3.8% | 66.60 | 69.00 | 66.60 | 87,077 | |
| 66.50 | +1.10 | +1.7% | 65.20 | 67.40 | 65.20 | 22,908 | |
| 65.40 | -0.70 | -1.1% | 66.30 | 66.40 | 64.80 | 34,306 | |
| 66.10 | -0.60 | -0.9% | 66.70 | 68.00 | 65.30 | 34,986 | |
| 66.70 | +2.20 | +3.4% | 64.80 | 66.90 | 64.10 | 50,394 | |
| 64.50 | -0.30 | -0.5% | 64.90 | 64.90 | 63.90 | 19,538 | |
| 64.80 | +0.30 | +0.5% | 64.40 | 64.80 | 63.20 | 21,467 | |
| 64.50 | +1.90 | +3.0% | 62.50 | 64.50 | 62.20 | 28,808 | |
| 62.60 | -1.50 | -2.3% | 64.00 | 64.00 | 62.30 | 29,816 | |
| 64.10 | -1.50 | -2.3% | 65.60 | 65.80 | 64.10 | 34,162 | |
| 65.60 | -0.10 | -0.2% | 66.00 | 67.10 | 65.30 | 42,090 | |
| 65.70 | +2.40 | +3.8% | 63.90 | 67.40 | 63.50 | 108,913 | |
| 63.30 | -0.20 | -0.3% | 63.60 | 63.80 | 62.70 | 39,067 | |
| 63.50 | -1.00 | -1.6% | 64.50 | 64.50 | 62.60 | 45,150 | |
| 64.50 | -0.90 | -1.4% | 65.40 | 66.00 | 64.50 | 29,170 | |
| 65.40 | -0.10 | -0.2% | 65.40 | 66.50 | 65.10 | 42,086 | |
| 65.50 | +0.20 | +0.3% | 65.80 | 66.50 | 65.40 | 48,673 | |
| 65.30 | +0.60 | +0.9% | 64.90 | 65.60 | 64.20 | 46,885 | |
| 64.70 | +0.10 | +0.2% | 64.00 | 64.70 | 63.40 | 64,913 | |
| 64.60 | -1.00 | -1.5% | 65.20 | 65.90 | 63.50 | 73,634 | |
| 65.60 | +3.10 | +5.0% | 62.80 | 65.60 | 62.80 | 174,654 | |
| 62.50 | +2.90 | +4.9% | 58.60 | 62.50 | 58.00 | 207,024 | |
| 59.60 | +5.40 | +10.0% | 57.10 | 59.60 | 57.10 | 258,145 | |
| 54.20 | +1.10 | +2.1% | 53.20 | 54.20 | 53.20 | 26,954 | |
| 53.10 | +0.10 | +0.2% | 53.20 | 53.60 | 52.70 | 29,468 | |
| 53.00 | +0.40 | +0.8% | 53.30 | 53.40 | 52.80 | 18,048 | |
| 52.60 | +0.60 | +1.2% | 52.20 | 52.70 | 51.90 | 44,686 | |
| 52.00 | -0.10 | -0.2% | 52.00 | 52.80 | 51.90 | 31,420 | |
| 52.10 | +0.30 | +0.6% | 52.00 | 52.40 | 51.80 | 11,367 | |
| 51.80 | +0.40 | +0.8% | 51.40 | 52.40 | 51.40 | 19,271 | |
| 51.40 | +0.70 | +1.4% | 50.80 | 51.60 | 50.70 | 22,714 | |
| 50.70 | +0.20 | +0.4% | 50.80 | 51.10 | 50.40 | 34,125 | |
| 50.50 | -0.50 | -1.0% | 51.20 | 51.40 | 50.50 | 24,955 | |
| 51.00 | -0.90 | -1.7% | 52.00 | 52.40 | 50.90 | 37,376 | |
| 51.90 | -0.30 | -0.6% | 52.00 | 52.80 | 51.50 | 18,751 | |
| 52.20 | -0.20 | -0.4% | 52.40 | 52.50 | 51.90 | 11,668 | |
| 52.40 | +0.60 | +1.2% | 52.00 | 53.20 | 51.70 | 22,475 | |
| 51.80 | -0.60 | -1.1% | 52.40 | 53.00 | 51.50 | 22,623 | |
| 52.40 | -0.20 | -0.4% | 52.60 | 53.00 | 52.30 | 22,187 |
- Ticker
- Aquis:BSLNZ
- Asset type
- Stock
- Exchange
- Aquis
- Currency
- CHF
What changed lately
Latest news release · Oct 27, 2026
Basilea raises full-year guidance 2026 and financial target for “Agenda 2030” and provides updates on late-stage clinical programs
Latest earnings call · Aug 18, 2026
Basilea Pharmaceutica (SIX Swiss: BSLN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 42 slides
Calls
Replays
Basilea Pharmaceutica (SIX Swiss: BSLN) Q2 2026 Earnings Call
Tue, Aug 18, 2026 · 10:00 AM ET
Watch Transcript
Latest news
Basilea raises full-year guidance 2026 and financial target for “Agenda 2030” and provides updates on late-stage clinical programs
Oct 27, 2026
Closed 72.20 (+4.8%) on Oct 27, 2026
Basilea reports presentation of new data for fosmanogepix, isavuconazole and ceftobiprole at IDWeek 2026
Oct 20, 2026
Closed 67.50 (-0.1%) on Oct 20, 2026
Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients
Sep 14, 2026
Closed 66.10 (-0.9%) on Sep 14, 2026
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
Aug 18, 2026
Closed 59.60 (+10.0%) on Aug 18, 2026
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
Aug 5, 2026
Closed 50.70 (+0.4%) on Aug 5, 2026
Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix
Jul 29, 2026
Closed 52.40 (+1.2%) on Jul 29, 2026
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
May 28, 2026
Closed 52.50 (-1.9%) on May 28, 2026
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
Apr 15, 2026
Closed 55.10 (-3.0%) on Apr 16, 2026
Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
Apr 9, 2026
Closed 54.10 (+1.5%) on Apr 9, 2026
Basilea announces start of first‑in‑human study of novel antibiotic BAL2420
Mar 23, 2026
Closed 51.50 (-1.2%) on Mar 23, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 42 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 43 slides · Oct 1, 2026
H1 2026 Earnings Presentation
Earnings · 70 slides · Aug 18, 2026
H1 2026 Earnings Presentation
Earnings · 29 slides · Aug 18, 2026
Basilea Pharmaceutica AG on 6ix
- News releases
- 20 in the last 12 months · 32 in all · newest Oct 27, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Aug 18, 2026
- Decks
- 5 decks · latest Oct 27, 2026
Where Basilea Pharmaceutica AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:BSLN · Home listing | SIX Swiss | Switzerland | CHF |
| LSE:0QNA | LSE | United Kingdom | CHF |
| gettex:PK5 | gettex | Germany | EUR |
| Aquis:BSLNZ · This page | Aquis | United Kingdom | CHF |
| OTC:BPMUF | OTC | United States | USD |
| Lang & Schwarz:A0B9GA | Lang & Schwarz | Germany | EUR |
| LS Exchange:A0B9GA | LS Exchange | Germany | EUR |
| Tradegate:PK5 | Tradegate | Germany | EUR |
| BX Swiss:PK5 | BX Swiss | Switzerland | CHF |
| Munich:PK5 | Munich | Germany | EUR |
| Turquoise:BSLNZ | Turquoise | United Kingdom | CHF |
| Dusseldorf:PK5 | Dusseldorf | Germany | EUR |
| Frankfurt:PK5 | Frankfurt | Germany | EUR |
| Hamburg:PK5 | Hamburg | Germany | EUR |
| Stuttgart:PK5 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Basilea Pharmaceutica AG.